Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors

Preliminary data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with higher mortality among cancer patients, particularly in those on systemic therapy. It is unclear whether this applies to patients receiving immune checkpoint inhibitors (ICIs). In...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabados, Bernadett, Abu-Ghanem, Yasmin, Grant, Michael, Choy, Julia, Bex, Axel, Powles, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association of Urology. Published by Elsevier B.V. 2020
Materias:
Case Series of the Month
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247982/
https://www.ncbi.nlm.nih.gov/pubmed/32534910
http://dx.doi.org/10.1016/j.eururo.2020.05.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247982/
https://www.ncbi.nlm.nih.gov/pubmed/32534910
http://dx.doi.org/10.1016/j.eururo.2020.05.024

Ejemplares similares